DuPont de Nemours, Inc. (DD) is held by 3 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 3 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $14.1M sold). 0 members of Congress reported 0 purchases vs 1 sale. Latest close $150.23 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 9, 2026 · Congress to Nov 16, 2026.
Hillman Capital Management · Mondrian Investment Partners · Dodge & Cox Funds — 3 tracked funds hold DD. See all holders.
Insiders bought on the open market (0 purchases, $0) vs 3 sales ($14.1M). Insider trading 0 members of Congress reported buying (0 purchases vs 1 sale). Politician trading
GSK plc (GSK) · FISERV INC (FISV) · THERMO FISHER SCIENTIFIC INC. (TMO) · DOW INC. (DOW) · ROGERS CORP (ROG) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Hillman Capital Management | 3.71% | 37,745 | TRIMMED (-4.0%) Q3 filed Nov 16 |
| Mondrian Investment Partners | 1.63% | 779,498 | TRIMMED (-1.0%) Q3 filed Oct 23 |
| Dodge & Cox Funds | <0.01% | 4,705 | TRIMMED (-3.8%) Q3 filed Nov 13 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +8.4% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 1,110 of 8,857 filers |
| Long-only filers among them | 1,107 |
| Change vs 2026 Q1 | -99 net · 952 entered · 1,051 exited |
| Shares reported, all filers | 98,728,737 |
| Reported value, all filers | $13.1B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Plastic Materials, Synth Resins & Nonvulcan Elastomers (SIC 2821) |
| Revenue · FY2025 | $6.8B |
| Net income · FY2025 | $-779.0M |
| Total assets · FY2025 | $21.6B |
| Shares outstanding | 135,042,975 |
| Market cap (at latest close) | $20.3B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.
| Shares short · Oct 15, 2026 | 4,689,753 |
| Share of shares outstanding | 3.47% |
| Days to cover | 5.99 |
Shares short at recent settlements — Jul 31, 2026: 5.2M · Aug 14, 2026: 3.8M · Aug 31, 2026: 4.8M · Sep 15, 2026: 4.9M · Sep 30, 2026: 5.1M · Oct 15, 2026: 4.7M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 3 sales by 3 insiders ($14.1M).
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Hoover Erik T. | SVP & General Counsel | Sell | 4,203 | $150.82 | $633.9K | SEC filing |
| Nov 9, 2026 | Koch Lori | CEO | Sell | 2,311 | $151.15 | $349.3K | SEC filing |
| Nov 5, 2026 | BREEN EDWARD D | Sell | 89,845 | $146.41 | $13.2M | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Larrabee Steven P. | Officer | 1,922 | $79.7K | Jan 5, 2026 | SEC filing |
| Dec 9, 2025 | Larrabee Steven P. | Officer | 72,958 | $3.0M | Dec 9, 2025 | SEC filing |
| Nov 28, 2025 | Hoover Erik T. | Officer | 6,005 | $239.0K | Nov 28, 2025 | SEC filing |
| Nov 28, 2025 | Koch Lori | Officer, Director | 9,011 | $355.6K | Nov 28, 2025 | SEC filing |
| Sep 4, 2025 | Larrabee Steven P. | Officer | 92,248 | $7.5M | Sep 4, 2025 | SEC filing |
| Nov 26, 2024 | Kemp Jon D. | Officer | 6,100 | $511.9K | Nov 26, 2024 | SEC filing |
| Jun 3, 2024 | Kemp Jon D. | Officer | 5,000 | $405.7K | Jun 3, 2024 | SEC filing |
| May 31, 2024 | Larrabee Steven P. | Officer | 3,100 | $252.4K | May 31, 2024 | SEC filing |
| May 9, 2024 | Goss Michael G. | Officer | 1,339 | $104.8K | May 9, 2024 | SEC filing |
| May 6, 2024 | Weaver Leland | Officer | 18,500 | $1.5M | May 6, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | STATE STREET CORPORATION | SC 13G | 6,958,558 | 5.1% | Jun 30, 2026 | SEC filing |
| Apr 29, 2026 | Vanguard Capital Management | SC 13G | 30,793,971 | 7.5% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
0 members of Congress reported buying (0 purchases vs 1 sale).
Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.
Recent activity by member
| Member | Chamber | Party | Buys | Sells | Latest | Amount range |
|---|---|---|---|---|---|---|
| Cisneros, Gilbert | House | D | 0 | 1 | Jul 17, 2026 | $1,001 - $15,000 |
Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.
Industry: Plastic Materials, Synth Resins & Nonvulcan Elastomers (SIC 2821). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 198 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Agriculture (87), Environment/Superfund (79), Transportation (75).
Federal contracts: $5.1M in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $1.4M |
| FY2022 | $2.3M |
| FY2023 | $1.2M |
| FY2024 | $154.1K |
| FY2025 | $43.9K |
| FY2026 | $-14.5K |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| SPE4A622P0233 | Department of Defense | $800.0K | Oct 5, 2021 |
| SPE4A622PH354 | Department of Defense | $491.7K | Apr 18, 2022 |
| SPE4A619PN317 | Department of Defense | $383.8K | Sep 11, 2019 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Politician BEST — appeared in 2 of the last 20 quarterly lists; latest 2021 Q4, ranked #28 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 4 | 25.0% | -4.7% | +2.9% | -7.6% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold DD — ranked by lift, the co-holding pattern described in Methodology: GSK plc (GSK) · FISERV INC (FISV) · THERMO FISHER SCIENTIFIC INC. (TMO) · DOW INC. (DOW) · ROGERS CORP (ROG) · EASTMAN CHEMICAL CO (EMN) · HEXCEL CORP /DE/ (HXL) · Merck & Co., Inc. (MRK).
5 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Nov 3, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 10, 2026 | 1.01 Entry into a Material Definitive Agreement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Aug 4, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
GSK plc (GSK) · Track Record: how the signals scored · Practice timing on DD
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.